Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-01-25 @ 11:05 AM
Study NCT ID:
NCT03829657
Status:
TERMINATED
Last Update Posted:
2023-01-20
First Post:
2019-01-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
Sponsor:
Theravance Biopharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-10
First Submit QC Date:
None
Study First Post Date:
2019-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-11-08
Results First Submit QC Date:
None
Results First Post Date:
2023-01-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-29
Last Update Post Date:
2023-01-20
Last Update Post Date Type:
ACTUAL